Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Immunovaccine Inc. is developing cancer vaccines using the companys DepoVaxTM vaccine technology. DepoVax is a patented formulation that displays excellent tumor control and provides a long lasting and specific effect. The way by which this vaccine exerts its effect is unclear but the translational team at Immunovaccine is determined to discover its mechanism of action and why their proprietary DepoVax technology delivers superior responses in comparison to other vaccines. This project will aim to figure out, using preclinical models, how the vaccines components are being transported within the immune system and which cells are responsible for this transport. The vaccine components will be labeled so that it can be tracked using magnetic resonance imaging (MRI) in the presence or absence of immune cells at the frontline of the immune system, like dendritic cells and macrophages. TO BE CONT’D
Kimberly Brewer
Marie-Laurence Tremblay
Immunovaccine Inc.
Visual arts
Life sciences
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.